US$ 29.05
glp 1 agonist liraglutide Des-Gly4)-Liraglutide GLP-1 Receptor Agonists as Treatments
Description
Outcomes Figure 1 shows the network of comparisons for the outcomes

Those with more acute symptoms often landed up spending many months in hospital being given a range of bland diets or milk drips

GLP-1 drugs, like Ozempic and Mounjaro, are dominating headlines for their ability to drive weight loss

Diet plays a major role

J Clin Invest (1993) 91:3017

A large study that compared tirzepatide to semaglutide showed that in non-diabetic, overweight adults, the risk of gastroparesis was much higher in semaglutide recipients compared to tirzepatide
